Gilead Price To Sales Ratio from 2010 to 2024
| GILD Stock | USD 66.93 0.38 0.56% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 3.72844372 | Current Value 3.54 | Quarterly Volatility 37.21083685 |
Check Gilead Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gilead main balance sheet or income statement drivers, such as Interest Expense of 534.5 M, Total Revenue of 28.5 B or Gross Profit of 28.5 B, as well as many exotic indicators such as Price To Sales Ratio of 3.54, Dividend Yield of 0.0485 or PTB Ratio of 7.85. Gilead financial statements analysis is a perfect complement when working with Gilead Sciences Valuation or Volatility modules.
Gilead | Price To Sales Ratio |
Latest Gilead Sciences' Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Gilead Sciences over the last few years. Price to Sales Ratio is figured by comparing Gilead Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Gilead Sciences sales, a figure that is much harder to manipulate than other Gilead Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. Gilead Sciences' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gilead Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 3.13 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Gilead Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 14.00 | |
| Geometric Mean | 5.27 | |
| Coefficient Of Variation | 265.76 | |
| Mean Deviation | 17.91 | |
| Median | 3.73 | |
| Standard Deviation | 37.21 | |
| Sample Variance | 1,385 | |
| Range | 145 | |
| R-Value | (0.46) | |
| Mean Square Error | 1,182 | |
| R-Squared | 0.21 | |
| Significance | 0.09 | |
| Slope | (3.79) | |
| Total Sum of Squares | 19,385 |
Gilead Price To Sales Ratio History
About Gilead Sciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Gilead Sciences income statement, its balance sheet, and the statement of cash flows. Gilead Sciences investors use historical funamental indicators, such as Gilead Sciences's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Gilead Sciences investors may use each financial statement separately, they are all related. The changes in Gilead Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Gilead Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Gilead Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Gilead Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 3.73 | 3.54 |
Gilead Sciences Investors Sentiment
The influence of Gilead Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Gilead. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Gilead Sciences' public news can be used to forecast risks associated with an investment in Gilead. The trend in average sentiment can be used to explain how an investor holding Gilead can time the market purely based on public headlines and social activities around Gilead Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Gilead Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Gilead Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Gilead Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Gilead Sciences.
Gilead Sciences Implied Volatility | 62.11 |
Gilead Sciences' implied volatility exposes the market's sentiment of Gilead Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gilead Sciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gilead Sciences stock will not fluctuate a lot when Gilead Sciences' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gilead Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gilead Sciences' short interest history, or implied volatility extrapolated from Gilead Sciences options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Gilead Sciences Correlation against competitors. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 3 | Earnings Share 4.5 | Revenue Per Share 21.728 | Quarterly Revenue Growth (0.04) |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.